|
?:authorAffiliation
|
-
[\'J.R. Curtis, MD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA.\', \'X. Zhou, PhD, Y. Chen, MD, B. Benda, MD, PhD, A. Madsen, PhD, J. Geier, PhD, Pfizer Inc, New York, New York, USA; xiaofeng.zhou@pfizer.com.\', \'D.T. Rubin, MD, University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.\', \'W. Reinisch, MD, Medical University of Vienna, Vienna, Austria.\', \'J. Yazdany, MD, Division of Rheumatology, Department of Medicine, University of California, San Francisco, California, USA.\', \'P.C. Robinson, MBChB, PhD, School of Clinical Medicine, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.\', \'X. Zhou, PhD, Y. Chen, MD, B. Benda, MD, PhD, A. Madsen, PhD, J. Geier, PhD, Pfizer Inc, New York, New York, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}